CLINICAL STUDIES
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1
Karen Sliwa, MD*  ,
Daniel Skudicky, MD*,
Anette Bergemann, MD* ,
Geoffrey Candy, MSc* ,
Adrian Puren, MD, PhD and
Pinhas Sareli, MD, FACC, FRCP*
* Department of Cardiology and Department of Nuclear Medicine, Baragwanath Hospital, Johannesburg, South Africa
Department of Hematology and Molecular Medicine, University of the Witwatersrand, Johannesburg, South Africa
Manuscript received May 11, 1999;
revised manuscript received October 5, 1999,
accepted November 17, 1999.
Reprint requests and correspondence: Dr. Daniel Skudicky, Department of Cardiology, Baragwanath Hospital, P.O. Bertsham 2013, Johannesburg, South Africa
psareli{at}iafrica.com
OBJECTIVES
1) To evaluate the outcome of patients with peripartum cardiomyopathy (PPC) on current treatment for heart failure, 2) to assess the circulating plasma levels of cytokines and Fas receptors and 3) to identify predictors of prognosis.
BACKGROUND
Previous studies in patients with PPC were done when angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic blocking agents were not routinely used in heart failure. Inflammatory cytokines play an important role in the pathogenesis and progression of heart failure of other etiologies. However, there is a paucity of data regarding cytokine expression in patients with PPC. Plasma concentrations of Fas receptors (an apoptosis-signalling receptor) have not been reported in this population.
METHODS
We followed prospectively 29 consecutive black women with PPC. All patients were treated with diuretics, digoxin, enalapril and carvedilol. Echocardiograms were performed at baseline and after six months of treatment. Cytokine and soluble Fas/APO-1 plasma levels were measured at baseline.
RESULTS
Tumor necrosis factor-alpha, interleukin-6 and Fas/APO-1 levels were significantly elevated in the study patients compared with 20 healthy volunteers. Eight patients died. sFas/APO-1 levels were significantly higher in patients who died compared with survivors (8.98 ± 4.5 vs. 5.33 ± 3 U/ml, respectively, p = 0.02). At six months, ejection fraction improved from 26.7 ± 10 to 42.7 ± 16%, p = 0.00003, with an increment of more than 10 U in 10 patients (28.1 ± 4 to 51.9 ± 8%, p = 0.000008).
CONCLUSIONS
Cytokine and sFas levels are elevated in patients with PPC. Despite treatment with ACE inhibitors and beta-blockers, mortality remains high. However, in 34% of the patients, left ventricular function almost completely normalized.
|
Abbreviations and Acronyms
| | ACE | = angiotensin-converting enzyme | | FC | = functional class | | iNOS | = inducible nitric oxide | | NYHA | = New York Heart Association | | PPC | = peripartum cardiomyopathy | | TNF | = tumor necrosis factor |
|
This article has been cited by other articles:
|
|
|
|
 
R. RAMARAJ and V. L. SORRELL
Peripartum cardiomyopathy: Causes, diagnosis, and treatment
Cleveland Clinic Journal of Medicine,
May 1, 2009;
76(5):
289 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S D Treadwell, B Thanvi, and T G Robinson
Stroke in pregnancy and the puerperium
Postgrad. Med. J.,
May 1, 2008;
84(991):
238 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kelly, P. M. Hickey, J. Davies, L. L. Ng, and D. Chin
Acute management of pregnancy associated cardiomyopathy with cardiac resynchronisation therapy
Eur J Heart Fail,
May 1, 2007;
9(5):
542 - 544.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C L Hu, Y B Li, Y G Zou, J M Zhang, J B Chen, J Liu, Y H Tang, Q Z Tang, and C X Huang
Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy
Heart,
April 1, 2007;
93(4):
488 - 490.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Trikas, C. Antoniades, G. Latsios, K. Vasiliadou, I. Karamitros, D. Tousoulis, C. Tentolouris, and C. Stefanadis
Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure
Eur J Heart Fail,
December 1, 2006;
8(8):
804 - 809.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sliwa, A. Damasceno, and B. M. Mayosi
Epidemiology and Etiology of Cardiomyopathy in Africa
Circulation,
December 6, 2005;
112(23):
3577 - 3583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Sheppard, M. Bedi, T. Kubota, M. J. Semigran, W. Dec, R. Holubkov, A. M. Feldman, W. D. Rosenblum, C. F. McTiernan, D. M. McNamara, et al.
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
J. Am. Coll. Cardiol.,
September 20, 2005;
46(6):
1036 - 1042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Elkayam, M. W. Akhter, H. Singh, S. Khan, F. Bitar, A. Hameed, and A. Shotan
Pregnancy-Associated Cardiomyopathy: Clinical Characteristics and a Comparison Between Early and Late Presentation
Circulation,
April 26, 2005;
111(16):
2050 - 2055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Quinn, B Doyle, and J McInerney
Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy
Emerg. Med. J.,
November 1, 2004;
21(6):
746 - 747.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. R. Pitts and C. F. Toombs
Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro
Am J Physiol Heart Circ Physiol,
October 1, 2004;
287(4):
H1801 - H1812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sliwa, D. Skudicky, G. Candy, A. Bergemann, M. Hopley, and P. Sareli
The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy
Eur J Heart Fail,
June 1, 2002;
4(3):
305 - 309.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Joashi, S. M. Tibby, C. Turner, A. Mayer, C. Austin, D. Anderson, A. Durward, and I. A. Murdoch
Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg.,
January 1, 2002;
123(1):
137 - 144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Mehta, R. N. Mehta, and I. A. Khan
Peripartum Cardiomyopathy: Clinical and Therapeutic Aspects
Angiology,
November 1, 2001;
52(11):
759 - 762.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Adamopoulos, J. T. Parissis, and D. Th. Kremastinos
A glossary of circulating cytokines in chronic heart failure
Eur J Heart Fail,
October 1, 2001;
3(5):
517 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
